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Background: Several guidelines on adeno-tonsillar disease have been proposed in recent years and some
discrepancies in relation both to clinical manifestations and indications for surgical treatment have emerged. The
aim of the study was to verify what influence (adeno)-tonsillectomy guidelines have had on the clinical behaviour
of ENT specialists in Italy. Our study is a retrospective and multi-centre case series with chart review.
Methods: The survey involved 14,770 children, aged between the ages of 2 and 11, who had undergone
adeno-tonsillar surgery between 2002 and 2008 in fourteen Italian tertiary and secondary referral centres. Anova
test was used for the statistical analysis, assuming p < 0.05 as the minimum statistical significance value.
Results: The frequency of adeno-tonsillar surgeries did not change significantly (p>0.05) during the study period
and following the Italian policy document publication. Overall, adeno-tonsillectomy was the most frequent
intervention (64.1%), followed by adenoidectomy (31.1%) and tonsillectomy (4.8%). The indications for surgery did
not change significantly for each of the operations (p>0.05), with the exception of adeno-tonsillectomy in case of
feverish episodes due to acute recurrent tonsillitis ≥ 5 without nasal obstruction (decreased p= 0.010) , even when
the feverish episodes due to acute recurrent tonsillitis were < 5 over the last year. Nasal obstruction was associated
with feverish episodes due to acute recurrent tonsillitis in 65.2% of operated cases, while otitis media had been
diagnosed in 43.3% of the patients studied.
Conclusions: The recommendations first developed in Italy in a 2003 policy document and then resumed in
guidelines in 2008, were not implemented by ENT units involved in the survey. The study highlights the fact that
the indications for adeno-tonsillar operations are based on the overall clinical presentation (comorbidity) rather
than on a single symptom. Guidelines are necessary to give coherent recommendations based on both the
findings obtained through randomized controlled trials and the data collected from observational studies.
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Table 1 The indications to pharyngeal surgical
interventions provided in the questionnaire
AT and T A
1. < 5 FEART a year without NRO * 1. < 5 FEART a year without NRO
2. < 5 FEART a year with NRO * 2. < 5 FEART a year with NRO
3. ≥ 5 FEART a year without NRO ° 3. ≥ 5 FEART a year without NRO
4. ≥ 5 FEART a year with NRO ° 4. ≥5 FEART a year with NRO
5. GABHS infection ° 5. NRO
AT = Adeno-Tonsillectomy; T = Tonsillectomy; A= Adenoidectomy; FEART =
Feverish Episodes due to Acute Recurrent Tonsillitis; NRO = Nasal Respiratory
Obstruction. GABHS = Group A β Hemolytic Streptococcus.
* not in accordance with Italian GL; ° in accordance with Italian GL.
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Several guidelines (GL) on adeno-tonsillar disease and
its treatment have been proposed in recent years by
scientific associations [1,2] or by institutions specifically
delegated to the drafting of such documents [3,4] in
order to standardize and rationalize indications for
(adeno)-tonsillectomy in children.
In Italy too, this topic has been the subject of a careful
study, carried out by a committee of experts appointed
by the Ministry of Health. In April 2003 the Italian
National System for Guidelines published a Policy Docu-
ment (PD) on adeno-tonsillar disease and its related sur-
gical treatments [5] and in March 2008, this document
was revised and resubmitted as GL [6]. Briefly the prin-
cipal indications developed in both documents are five
or more feverish episodes due to acute recurrent tonsi-
llitis (FEART) in a single year and the presence of
obstructive sleep apnoea syndrome (OSAS).
Moreover, some of the currently known GL on adeno-
tonsillar disease have been revised over the years with
significant modifications to both the key parameters,
related to surgical interventions, and the forcefulness of
recommendations [1-4].
The apparent discrepancies in the different GL relate
mainly to those clinical manifestations which give an
indication for surgery, but also to the number and
strength of the various recommendations contained in
these documents. The true value of the criticism raised
against the GL should be evaluated, keeping in mind
that verification was also sought by the American
Academy of Otolaryngology-Head and Neck Surgery
(AAOHNS), that acknowledged the requirement for
research to assess “the impact and use of the guidelines by
determining how the guidelines translate to performance
measurements and performance improvement” [2].
The degree of acceptance of the recommendations in
the surgical guidelines set out by Italian ENT specialists
in the mentioned documents is not known to date.
The present study intends to determine whether, as a
result of the recommendations concerning the clinical
indications to (adeno)-tonsillectomy contained in the
2003 PD [5] and confirmed by the 2008 GL [6], the fre-
quency of adeno-tonsillar surgery has changed over the
last years in the ENT units included in the survey and if
the otolaryngologists involved have modified their be-
haviour in line with the indications for these surgical
interventions.
Methods
Fourteen Italian tertiary and secondary referral centers
including ENT units were recruited for the present
research, 10 of which (6 university hospitals and 4 hospi-
tals) operating in general hospitals and 4 in paediatric
hospitals.The participating centres were selected from a pre-
vious epidemiologic survey [7] conducted by means of a
questionnaire on number and type of adeno-tonsillar
surgical intervention which had been sent to ENT pae-
diatric surgical centres in Italy. 14 centres, distributed
on the Italian territory, answered fully. Our observation
refers to data obtained by the recruited centres and thus
represent the clinical behaviour of the ENT specialists
involved in the survey. None of the researchers of this
survey was involved in the authorship of the guidelines.
The present research was performed in accordance
with the institutional review board guidelines, as well as
the Helsinki Declaration of 1983, and it has been
reviewed and approved by the Ethics Committee of the
School of Medicine Federico II, Naples, Italy (no 42/12).
The medical directors of the ENT units involved were
first requested to fill in a questionnaire regarding the
medical records of the years 2002, 2004, 2006, 2008
related to children, aged between 2 and 11, who had
undergone adeno-tonsillar surgery (Adeno-Tonsillectomy,
AT; Tonsillectomy, T; Adenoidectomy, A).
With regards to tonsillar surgery, the data provided by
the recruited centres included only tonsillectomy - to
the best of our knowledge - tonsillotomy is rarely per-
formed in Italy.
After which, they were asked to identify the indica-
tions provided for each of the three operations studied,
on the basis of five different clinical presentations
(Table 1) both for AT and T then for A, with reference
to the number of FEART suffered over the last year
(≥ 5, in accordance with Italian GL; or < 5, not in
accordance with Italian GL) , the presence of nasal re-
spiratory obstruction (NRO) in association with FEART
(AT and T) or even as exclusive clinical manifestation
(A), and elevated Antistreptolysin O (ASO) titer with
distant disorders possibly due to group A β hemolytic
streptococcus infection (GABHS).
As far as the number of FEART is concerned, the
patients were divided into two groups depending on the
number of feverish episodes (≥ 5 or < 5) suffered in the
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possibility of GABHES infection was indicated if the
ASO titer was double or more the upper limit of the
normal range, regardless of test technique used.
The severity of NRO due to pharyngeal lymphatic
tissue hyperplasia (frequent colds with occasional or per-
sistent nasal discharge; open mouth respiration during
daytime and/or during night sleep, with or without
association of brief and sporadic episodes of sleep
apnoea; snoring; prolonged and frequent episodes of
sleep apnoea) was not evaluated as not useful to the aim
of the present study. As for tympanic inflammations, the
presence of persistent and/or recurrent effusive otitis
media (EOM) had to be documented by clinical exami-
nation and by type B tympanogram recorded at least
three times in the 12 months prior to surgical interven-
tion; the diagnosis of acute recurrent otitis media
(AROM) was formulated in the case of at least 4 acute
episodes over the previous year, or 3 episodes occurring
over the previous six months. Anova test was used for
the statistical analysis (statistical package SPSS, 10.3 ver-
sion; Boston – USA) assuming p < 0.05 as the minimum
statistical significance value.Results
The fourteen units involved in the study provided data
relative to 14,770 subjects operated on during the study
period, of whom 9,469 cases underwent AT, 714 T and
4,587 A. Overall, AT represented the most frequent
operation (64. 1%), followed by A (31.1%) and finally T
(4.8%) with the lowest incidence (Figure 1). None of the
three types of pharyngeal operations underwent any sig-










Figure 1 Trends of operated cases. The dashed line indicates the introd
T = Tonsillectomy; A= Adenoidectomy.The indications for AT remained fairly constant in the
study period (p> 0.05), except for FEART ≥5 in the pre-
vious year without NRO (decreased; p= 0.010) , even
when FEART were < 5 over the previous year with
( p = 1) or without NRO (p = 0.539). In 76.1% of cases
the indication for AT depended on the association
between FEART with NRO (Table 2).
The indications for T were relatively irregular in rela-
tion to the extremely low number of cases (4.8% of the
study patients). In this group the most frequent indica-
tion (74.5% on average) was constituted by FEART ≥5,
of which 40.1% were subjects in whom surgical indica-
tion arose as the consequence of the simultaneous pre-
sence of FEART and NRO. The indication for surgical
treatment was due to FEART <5 without NRO (Tab. 2),
with a percentage varying during the study from 1.8% to
10.9% of these cases.
The indications for A predominantly involved patients
with NRO (75.0%). The simultaneous presence of
FEART and NRO brought 46.6% of these cases to sur-
gery (Table 2).
Overall, out of 14,770 patients who underwent surgical
treatment, 6396 (43.3%) complained of recurrent AROM
and/or EOM; the frequency of otitis media in patients
who underwent surgical interventions showed no signifi-
cant variation (p>0.05) during the years of the study.
Discussion
The principal aim of our survey was to verify the degree
of acceptance of the Italian GL by specialists directly
involved in the research. In this regard the authors of
the Italian GL assumed that the dissemination of the PD
was adequate and that a reduction in the number of ton-





uction of PD in 2003 in Italy. AT = Adeno-Tonsillectomy;
Table 2 Trend in absolute numbers and percentages of AT, T and A
Study year P*
2002 2004 2006 2008 Total 2002-2008
AT
< 5 FEART without NRO 56 (2.3%) 47 (2.0%) 43 (1.8%) 44 (2.0%) 190 (2.0%) 0.539
< 5 FEART with NRO 855 (34.5%) 955 (41.3%) 914 (37.5%) 809 (36.1%) 3533 (37.3%) 1
≥ 5 FEART without NRO 344 (13.9%) 309 (13.4%) 268 (11.0%) 235 (10.5%) 1156 (12.2%) 0.010
≥ 5 FEART with NRO 990 (40.0%) 779 (33.7%) 984 (40.4%) 920 (41.0%) 3673 (38.8%) 0.637
GABHS infection 233 (9.4%) 223 (9.6%) 227 (9.3%) 234 (10.4%) 917 (9.7%) 0.553
Total AT 2478 2313 2436 2242 9469 0.307
(100%) (100%) (100%) (100%) (100%)
T
< 5 FEART without NRO 6 (4.3%) 24 (10.9%) 9 (4.8%) 3 (1.8%) 42 (5.9%) 0.605
< 5 FEART with NRO 9 (6.5%) 25 (11.3%) 23 (12.4%) 20 (11.8%) 77 (10.8%) 0.132
≥ 5 FEART without NRO 72 (52.2%) 106 (48.0%) 74 (39.8%) 71 (42.0%) 323 (45.2%) 0.109
≥ 5 FEART with NRO 40 (29.0%) 46 (20.8%) 58 (31.2%) 65 (38.5%) 209 (29.3%) 0.317
GABHS infection 11 (8.0%) 20 (9.0%) 22 (11.8%) 10 (5.9%) 63 (8.8%) 0.845
Total T 138 221 186 169 714 0.784
(100%) (100%) (100%) (100%) (100%)
Total AT+T 2616 (100%) 2534 2622 2411 10183 0.309
(100%) (100%) (100%) (100%) (100%)
A
< 5 FEART without NRO 285 (21.9%) 237 (20.4%) 293 (28.1%) 265 (24.6%) 1080 (23.5%) 0.373
< 5 FEART with NRO 379 (29.1%) 282 (24.3%) 254 (24.3%) 277 (25.7%) 1192 (26.0%) 0.508
≥ 5 FEART without NRO 25 (1.9%) 17 (1.5%) 9 (0.9%) 13 (1.2%) 64 (1.4%) 0.225
≥ 5 FEART with NRO 241 (18.5%) 259 (22.3%) 236 (22.6%) 211 (19.6%) 947 (20.6%) 0.592
NRO 373 (28.6%) 367 (31.6%) 252 (24.1%) 312 (28.9%) 1304 (28.4%) 0.689
Total A 1303 1162 1044 1078 4587 0.113
(100%) (100%) (100%) (100%) (100%)
AT = Adeno-Tonsillectomy; T = Tonsillectomy; A= Adenoidectomy; FEART = Feverish Episodes due to Acute Recurrent Tonsillitis; NRO = Nasal Respiratory
Obstruction. GABHS = Group A β Hemolytic Streptococcus.
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however, partially in contrast with the data of Fedeli
et al. who found a wide heterogeneity in AT rates
according to nationality and local health units in Veneto
(Italy) after the publication of the PD in 2003 [8].
During the study period (from 2002, one year before the
PD publication, to 2008, 5 years after the publication of
the document) the overall number of (A)T and A effected
in the recruited units showed no significant variation. This
data tends to exclude the real impact of the recommenda-
tions formulated in the 2003 PD on the clinical behaviour
of ENT specialists included in the survey, at least for the
containment of adeno-tonsillar operations.
As previously reported, PD is widespread in Italy, and
it can be assumed that most of the ENT specialists - and
among them certainly the specialists involved in the
present investigation - were well aware of the recom-
mendations expressed in these documents.
The clinical manifestations that generally lead to indi-
cations for adeno-tonsillar surgery are very differentlyinterpreted by the various GL (Table 3) [1-6]. As for the
FEART, almost all GL refer to the study of Paradise et al
[9], according to which (A)T should be proposed in
cases of 7 or more episodes of tonsillitis over the pre-
vious year, 5 or more episodes per year in the previous 2
years, or even 3 or more episodes per year in the pre-
vious 3 years. Nevertheless, the indications reported in
the cited GL [1-6] do not always adhere to these criteria:
surgery has in fact been proposed after 5 or more
FEART in the previous year in the GL published in 1999
by Scottish Intercollegiate Guidelines Network (SIGN)
[3]; after 3 or more episodes in the Clinical Indicators
Compendium published by AAOHNS in 2000 [1]; after
5 or more episodes in the PD (2003) [5] and GL (2008)
[6] published in Italy. Only in 2010 SIGN [4] and in
2011 AAOHNS [2] proceeded to a new formulation of
the GL adopting the criteria formulated by Paradise
et al. in 1984 [9].
In the present study, the indication for AT and T was
given in 37.7% of the patients in relation to a number of






NRO Otitis media Number of
recommendations
SIGN: 1999 3 ≥ 5 a year C/A-C Not mentioned Not mentioned 3
AAOHNS:
2000 1
≥ 3 a year - Hypertrophy causing
upper airway obstruction
RAOM or EOM 8
PNLG: 2003 5 ≥ 5 a year A/A-D OSAS Surgery is not
recommended
53
SNLG 2008 6 ≥ 5 a year A/A-D OSAS Surgery is not
recommended
79
SIGN: 2010 4 ≥ 7 in the last
year
D/A-D Not mentioned Not mentioned 4
≥ 5 in the last 2
years




≥ 7 in the last
year
B/A-D Sleep Disordered Breathing (SDB),
including snoring, mouth breathing,
pauses in breathing, etc.
(“comorboid conditions”)
Not mentioned 10
≥ 5 in the last 2
years
≥ 3 in the last 3
years
GL = Guidelines; FEART = Feverish Episodes due to Acute Recurrent Tonsillitis; NRO = Nasal Respiratory Obstruction. SIGN = Scottish Intercollegiate Guidelines
Network; AAOHNS = American Academy of Otolaryngology-Head and Neck Surgery; PNLG =Programma Nazionale Linee Guida; SNLG = Sistema Nazionale Linee
Guida. Strength of the recommendation related to the number of FEART.
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thermore, the incidence of patients who underwent T
with FEART <5 without other clinical manifestations
increased to 10.9% in 2004, suggesting that the ENT sur-
geons involved in the present survey did not apply the
recommendations formulated in the PD [5].
Some GL do not consider NRO and its clinical relation-
ship with sleep-disordered breathing, while others ap-
proach this issue in very different ways. For instance, the
GL published by SIGN [3,4] does not mention this aspect
at all, excluding it from its assessment. On the other hand,
the AAOHNS [1] GL (2000) refers to all adeno-tonsillar
hypertrophies as responsible for obstructive respiratory
disease. Italian PD [5] and GL [6] prefer to give relevance
only to cases with OSAS documented instrumentally, such
as pulse oxymetry and polysomnography. Finally, the
AAOHNS GL of 2011 [2] draws attention to children in
whom sleep-disordered breathing, comorboid conditions
(growth retardation, poor school performance, enuresis
and behavioral problems) and tonsillar hypertrophy are
susceptible to improvement after surgical treatment.
In the present study NRO was frequently observed in
patients, often in association with FEART (65.2%). Cli-
nical manifestations related to NRO as a whole should
not be ignored by GL or similar documents, as they
could be linked to several behavioural modifications that
necessarily influence the QoL, creating anxiety in
parents [10].The different GL also show discrepancies regarding
the role of adeno-tonsillar surgery in the management of
otitis media: the GL of the SIGN [3,4] and that devel-
oped by the AAOHNS in 2011 [2] do not consider otitis
media as an indication for surgery. The GL of the
AAOHNS published in 2000 [1] recommend A associated
with T for AROM and EOM. Otherwise, the Italian PD [5]
and GL [6] consider the suitability of A only in cases when
EOM is non responsive to medical treatments, associated
with chronic adenoiditis. In our study, 43.3% of the
patients who underwent surgical treatments had tympanic
inflammations, suggesting a strong correlation between
otitis media and adeno-tonsillar disease.
The indications for T, with or without A, derived in
most of the study cases, from the concurrent presence of
several clinical manifestations related to adeno-tonsillar
disease (comorbidity). For instance, association between
FE and NRO was observed in 73.6% of the patients who
underwent AT and T: these data raise many doubts con-
cerning the real importance of defining precise parameters
for each of these clinical manifestations and show that, for
surgical indication, each clinical manifestation alone is less
conclusive than their association.
As is well known, the recommendations of the GL
must adhere to the principles of Evidence-Based Medi-
cine, which assume more strength and credibility when
based on studies with a high level of evidence and, in
particular, on randomized controlled studies.
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followed by subsequent studies by the same group [11]
and by those of other researchers [12,13], were undoubt-
edly essential in this topic. However, several authors
have raised objections to these studies [14-16], pointing
out the possibility of bias in the investigation technique
and the scarse acknowledgement of relations existing
between the different pathological conditions related to
adeno-tonsillar disease [17-20].
Arguing that surgical treatment is indicated only if
FEART are >7 [9] is simplistic for us: such treatment
could be considered unquestionably valid also in cases
with a lower number of feverish episodes, but with signs
of significant upper airway obstruction, recurrent tym-
panic inflammations or positivity for GABHES infection
[21]; in this respect, the criticism of Darrow and
Siemens [15], who analyzed the various symptoms of
chronic adeno-tonsillitis, and the remarks of van den
Akker et al. [22] on the possibilities of various therapies
in order to treat the overall clinical picture, seem to us
particularly relevant.
With regard to the analysis of the relations between
GL and otitis media, we should refer to the study of
Paradise et al. [11] 1999, who discussed the statistical
assumptions of their study with particular precision.
Unfortunately, the considerable dispersion of data
reduces the reliability of the reported remarks for the
present study too. Moreover, the fact that the majority
of patients (72.6%) of the 3-way trial underwent a surgi-
cal treatment (A or AT), which is considered risky by
the authors, without there having been any clear indica-
tion for surgery, and that 66.2% of patients of the 2-way
trial were operated on for AT without any nasal obstruc-
tion attributable to large adenoid, raises some concerns.
These are biases that stand in contrast to each other
and negatively effect the results and the conclusions of
the investigation, especially with regards to children
affected by clinical manifestations suggestive of adeno-
tonsillar disease and with a more severe clinical course
[23]. Some of the comments made in the study of Paradise
et al., regarding the lack of representativeness of the
series, the high incidence of cases lost to follow-up, the
high proportion of control cases that underwent surgical
treatment during the investigation, the inclusion of these
patients in control cases, could be extended to other
investigations [24]. Results obtained from this study
regarding the scant acceptance of Italian GL recom-
mendations by the ENT specialists involved in the survey,
may show the reluctance on behalf of some specialists
to change a rooted clinical behaviour. Nevertheless such
data demonstrates that the variability of surgical indica-
tions suggested by ENT specialists is based on the pre-
sence of several contemporaneous clinical manifestations,
a characteristic aspect of adeno-tonsillar disease which isnot given sufficient attention in GL written in Italy or in
other countries.
The results of our study naturally do not intend to for-
mulate strict rules or even substitute the GL. They are
intended to point out that the recommendations for ton-
sillectomy proposed by GL do not always coincide with
the clinical indications, especially in the presence of
comorbidity.
In our opinion, the limitations in the studies based on
RCTs, imposed by the stringent rules governing patient
recruitment and the assessment criteria, mean that
results do not accurately reflect the clinical reality in
some application areas, such as the present one.
Rosenfeld, co-editor with Bluestone of a meticulous
monography on otitis media [25], notes that it is dange-
rous to classify all the published randomized trials as
high quality and all the observational studies as poor
quality research and that randomization can not substi-
tute imprecise selection criteria, poorly defined objec-
tives, inadequate follow-up, or reduced compliance to
treatment. This last remark supports the view of Schon
and Stanley [26] on the need to consider the RCTs and
the studies based on clinical experience or observational
studies as complementary.
Conclusions
The present study analyses the effects that guidelines on
(adeno)-tonsillar surgery had on the clinical behavior of
ENT specialists in Italy. The results of this study show
that the recommendations in these documents did not
led to changes in practice for these operations, in the
recruited ENT units. Current guidelines, such as the
Italian GL, generally recommend (adeno)-tonsillectomy
only if at least 5 feverish episodes have occurred in the
last year. In most of the patients studied, however, the
indication for surgery was the presence of comorbidity
represented by various and concurrent clinical manifes-
tations. Although some of the published guidelines men-
tion comorbidity, none of them report recommendations
with specific reference to this issue. Our findings raise
many doubts on the real importance of defining precise
parameters for each of the clinical manifestations related
to adeno-tonsillar disease and on the true correspon-
dence to clinical reality of the recommendations laid
down in some of these documents, which might justify
the apparent disregard for them in current practice. We
consider it appropriate, therefore, to propose a revision
of the guidelines to unify their orientations in order to
guarantee patients’ health and to protect the prestige
and professionalism of surgeons, too often involved in
legal disputes that have only speculative purposes.
Further studies will certainly be needed to critically
analyze GL on (adeno)-tonsillectomy (and related topics)
and to determine the reasons that lead ENT practitioners
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